Diagnosed hematological malignancies in Bangladesh - A retrospective analysis of over 5000 cases from 10 specialized hospitals

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Hossain, Mohammad S ^a   Iqbal, Mohd S ^b,m   Khan, Mohiuddin A ^c   Rabbani, Mohammad G ^d   Khatun, Hazera ^e   Munira, Sirajam ^d   Miah, M Morshed Z ^f   Kabir, Amin L ^g   Islam, Naima ^h   Dipta, Tashmim F ⁱ   Rahman, Farzana ^j   Mottalib, Abdul ⁱ   Afrose, Salma ^c   Ara, Tasneem ^c   Biswas, Akhil R ^c   Rahman, Mizanur ^c   Abedin, Akm M ^l   Rahman, Mahbubur ^h   Yunus, Abm ^j,k   Niessen, Louis W ^b,n   Sultana, Tanvira A ⁱ   more..

^a BRAC UNIVERSITY   (Bangladesh)

^b Centre for Control of Chronic Diseases (CCCD) Icddrb   (Bangladesh)

^c DHAKA MEDICAL COLLEGE HOSPITAL   (Bangladesh)

^d CHITTAGONG MEDICAL COLLEGE HOSPITAL   (Bangladesh)

^e Square Hospital Ltd ^*  (Bangladesh)

^f Rajshahi Medical College Hospital   (Bangladesh)

^g Delta Medical College and Hospital   (Bangladesh)

^h National Cancer Research Institute and Hospital   (Bangladesh)

ⁱ Bangladesh Institute of Research and Rehabilitation in Diabetes Endocrine and Metabolic Disorders   (Bangladesh)

^j BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^k Green View Clinic   (Bangladesh)

^l Bangladesh rhriaz29 gmailcom https: orcidorg 0000 0003 4162 9545   (Bangladesh)

^m Centre for Nutrition and Food Security   (Bangladesh)

ⁿ LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

ALL; AML; Bangladesh; CML; Hematological malignancy; HL; MDS; MM; NHL

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BANGLADESH; CANCER CENTER; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; POPULATION DISTRIBUTION; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; CLASSIFICATION; HEMATOLOGIC NEOPLASMS; MIDDLE AGED; PRESCHOOL CHILD; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BANGLADESH; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84902072357     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-438     Document Type: Article

References (37)

1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence, mortality and prevalence worldwide in 2012: GLOBOCAN 2012 v1.0 Lyon, France: International Agency for Research on Cancer, http://globocan.iarc.fr/Default.aspx 2013.
2. WHO Global status report on noncommunicable diseases 2010. Description of the global burden of NCDs, their risk factors and determinants 2011, WHO.
3. Das P, Horton R. Bangladesh: innovating for health. Lancet 2013, 382(9906):1681-1682. 10.1016/S0140-6736(13)62294-1, 24267987.
4. Hussain SA, Sullivan R. Cancer control in bangladesh. Jpn J Clin Oncol 2013, 43(12):1159-1169. 10.1093/jjco/hyt140, 3842101, 24163419.
5. Story HL, Love RR, Salim R, Roberto AJ, Krieger JL, Ginsburg OM. Improving outcomes from breast cancer in a low-income country: lessons from Bangladesh. Int J Breast Cancer 2012, 2012:423562. 3262600, 22295245.
6. Gopal S, Wood WA, Lee SJ, Shea TC, Naresh KN, Kazembe PN, Casper C, Hesseling PB, Mitsuyasu RT. Meeting the challenge of hematologic malignancies in sub-Saharan Africa. Blood 2012, 119(22):5078-5087. 10.1182/blood-2012-02-387092, 22461494.
7. Park HJ, Park EH, Jung KW, Kong HJ, Won YJ, Lee JY, Yoon JH, Park BK, Lee H, Eom HS, Park S. Statistics of hematologic malignancies in Korea: incidence, prevalence and survival rates from 1999 to 2008. Korean J Hematol 2012, 47(1):28-38. 10.5045/kjh.2012.47.1.28, 3317467, 22479275.
8. Wu SJ, Huang SY, Lin CT, Lin YJ, Chang CJ, Tien HF. The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: a distinct increasing trend with birth-cohort effect. Blood 2010, 116(22):4430-4435. 10.1182/blood-2010-05-285221, 20713960.
9. Fey MF. Salient features of hematological diseases. Ann Oncol 2007, 18(Suppl 1):i54-i64.
10. Lichtman MA. Battling the hematological malignancies: the 200 years' war. Oncologist 2008, 13(2):126-138. 10.1634/theoncologist.2007-0228, 18305057.
11. Rodriguez-Abreu D, Bordoni A, Zucca E. Epidemiology of hematological malignancies. Ann Oncol 2007, 18(Suppl 1):i3-i8.
12. Bhutani M, Vora A, Kumar L, Kochupillai V. Lympho-hemopoietic malignancies in India. Med Oncol 2002, 19(3):141-150. 10.1385/MO:19:3:141, 12482124.
13. BRAC Bangladesh Health System in Transition: Selected Articles (2008). https://www.k4health.org/sites/default/files/bangladesh_health_system_in_transition.pdf, BRAC.
14. American Cancer Society Cancer facts & figures 2012 Atlanta: American cancer society, http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2012, American Cancer Society.
15. Akarolo-Anthony SN, Ogundiran TO, Adebamowo CA. Emerging breast cancer epidemic: evidence from Africa. Breast Cancer Res 2010, 12(Suppl 4):S8. 10.1186/bcr2737, 3005728, 21172092.
16. Parkin D, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas J, Wabinga H, Whelan S. Cancer in Africa: Epidemiology and Prevention 2003, IARC: Lyon.
17. Au WY, Caguioa PB, Chuah C, Hsu SC, Jootar S, Kim DW, Kweon IY, O'Neil WM, Saikia TK, Wang J. Chronic myeloid leukemia in Asia. Int J Hematol 2009, 89(1):14-23. 10.1007/s12185-008-0230-0, 19101781.
18. Mozaheb Z. Epidemiology of Lymphoid Malignancy in Asia, Epidemiology Insights. Tech 325-354. Dr. Maria De Lourdes Ribeiro De Souza Da Cunha, doi:10.5772/31746. Available from: http://www.intechopen.com/books/epidemiology-insights/epidemiology-of-lymphoid-malignancy-in-asia. SBN: 978-953-51-0565-7.
19. Matsuda A, Germing U, Jinnai I, Misumi M, Kuendgen A, Knipp S, Aivado M, Iwanaga M, Miyazaki Y, Tsushima H, Sakai M, Bessho M, Tomonaga M. Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes. Blood 2005, 106(8):2633-2640. 10.1182/blood-2005-01-0040, 15972453.
20. Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India. Indian J Cancer 2009, 46(4):264-273. 10.4103/0019-509X.55546, 19749456.
21. Alexander FE. The search for causes of the leukaemias. Eur J Cancer 1995, 31A(6):863-867.
22. Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, Devesa SS, McGlynn KA. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 2009, 18(4):1174-1182. 10.1158/1055-9965.EPI-08-1118, 2793271, 19293308.
23. Gorini G, Stagnaro E, Fontana V, Miligi L, Ramazzotti V, Nanni O, Rodella S, Tumino R, Crosignani P, Vindigni C, Fontana A, Vineis P, Costantini A. Alcohol consumption and risk of leukemia: a multicenter case-control study. Leuk Res 2007, 31(3):379-386. 10.1016/j.leukres.2006.07.002, 16919329.
24. Linet MS, Devesa SS, Morgan GJ. The leukemias. Cancer epidemiology and prevention 2006, 841-871. New York: Oxford University Press, Schottenfeld D, Fraumeni JJr, 3, 2006.
25. SEER Cancer Statistics Review 2012, http://seer.cancer.gov/statfacts/html/hodg.html.
26. Pulte D, Redaniel MT, Jansen L, Brenner H, Jeffreys M. Recent trends in survival of adult patients with acute leukemia: overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups. Haematologica 2012, 98(2):222-229. 3561429, 22929974.
27. Ibrahim ME, Osman EI. Myeloid Leukemia: A Molecular Focus on Etiology and Risk Within Africa, Myeloid Leukemia - Basic Mechanisms of Leukemogenesis. Tech 465-484. Dr Steffen K, DOI: 10.5772/27359. Available from: http://www.intechopen.com/books/myeloid-leukemia-basic-mechanisms-of-leukemogenesis/myeloid-leukemia-a-molecular-focus-on-etiology-and-risk-within-africa. SBN: 978-953-307-789-5.
28. Hamad HM. Cancer initiatives in Sudan. Ann Oncol 2006, 17(Suppl 8):viii32-viii36.
29. Gogia A, Sharma A, Raina V, Kumar L, Vishnubhatla S, Gupta R, Kumar R. Assessment of 285 cases of chronic lymphocytic leukemia seen at single large tertiary center in Northern India. Leuk Lymphoma 2012, 53(10):1961-1965. 10.3109/10428194.2012.672734, 22475243.
30. Tamura K, Sawada H, Izumi Y, Fukuda T, Utsunomiya A, Ikeda S, Uike N, Tsukada J, Kawano F, Shibuya T, Gondo H, Okamura S, Suzumiya J. Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan. Eur J Haematol 2001, 67(3):152-157. 10.1034/j.1600-0609.2001.5790514.x, 11737247.
31. Clarke CA, Glaser SL, Gomez SL, Wang SS, Keegan TH, Yang J, Chang ET. Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation. Cancer Epidemiol Biomarkers Prev 2011, 20(6):1064-1077. 10.1158/1055-9965.EPI-11-0038, 3111874, 21493873.
32. Arora N, Manipadam MT, Nair S. Frequency and distribution of lymphoma types in a tertiary care hospital in South India: analysis of 5115 cases using the World Health Organization 2008 classification and comparison with world literature. Leuk Lymphoma 2013, 54(5):1004-1011. 10.3109/10428194.2012.729056, 22971239.
33. Omoti CE, Nwannadi AI, Obieche JC, Olu-Eddo AN. The epidemiological features of lymphoid malignancies in Benin City, Nigeria: a 15 years study. Pan Afr Med J 2012, 11:10. 3283024, 22368753.
34. Kumar L, Verma R, Radhakrishnan VR. Recent advances in the management of multiple myeloma. Natl Med J India 2010, 23(4):210-218.
35. Waxman AJ, Mink PJ, Devesa SS, Anderson WF, Weiss BM, Kristinsson SY, McGlynn KA, Landgren O. Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood 2010, 116(25):5501-5506. 10.1182/blood-2010-07-298760, 3031400, 20823456.
36. Kar R, Rao S, Saxena R. Myelodysplastic syndromes: classification and prognostic scoring systems and their applicability in Indian scenario-experience from a tertiary care center. Hematology 2009, 14(3):145-149. 10.1179/102453309X402232, 19490759.
37. Gattermann N. Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload. Int J Hematol 2008, 88(1):24-29. 10.1007/s12185-008-0118-z, 2516534, 18581200.